HENRY SCHEIN INC
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/27/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 3,107 | 48.9 |
| Stockholders' equity | 3,245 | 51.1 |
| Total capitalization | 6,352 | 100.0 |
111,446,542 shares outstanding at 27 July 2026 (cover page of the 10-Q filed 4 August 2026).
LONG-TERM DEBT 12/27/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 2,343 |
| Long-term debt, noncurrent | 2,310 |
| Current maturities | 33 |
| Short-term borrowings / commercial paper | 764 |
CAPITAL STOCK 12/27/25
| Common shares authorized | 480,000,000 |
| Common shares issued | 115,771,149 |
| Par or stated value per share ($) | 0.01 |
| Outstanding at 7/27/26 | 111,446,542 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | – | – |
| 2022 | – | – |
| 2021 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as SCHEIN HENRY INC (to 19 June 2006).
BUSINESS: Classified by the SEC under Standard Industrial Classification 5047, Wholesale-Medical, Dental & Hospital Equipment & Supplies. Large accelerated filer. Principal executive office: 135 Duryea Rd, Melville, NY 11747. Fiscal year ends December 26. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/27/25 | 12/28/24 | 12/30/23 |
|---|---|---|---|
| Revenues | 13,184 | 12,673 | 12,339 |
| Cost of revenues | 9,079 | 8,657 | 8,479 |
| Gross profit | 4,105 | 4,016 | 3,860 |
| Selling, general and administrative | 3,084 | 3,034 | 2,956 |
| Depreciation and amortization | 311 | 297 | 248 |
| Operating income | 653 | 621 | 615 |
| Interest expense | 150 | 131 | 87 |
| Income before income taxes | 533 | 513 | 542 |
| Income taxes | 126 | 128 | 120 |
| Net income | 398 | 390 | 416 |
| Earned per share, diluted ($) | 3.27 | 3.05 | 3.16 |
| Dividends per share ($) | – | – | – |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/27/25 | 12/28/24 |
|---|---|---|
| Receivables, net | 1,651 | 1,482 |
| Inventories | 2,002 | 1,810 |
| Total current assets | 4,464 | 3,983 |
| Property, plant and equipment, net | 621 | 531 |
| Goodwill | 4,213 | 3,887 |
| Total assets | 11,215 | 10,218 |
| Total current liabilities | 3,228 | 2,803 |
| Long-term debt | 2,310 | 1,830 |
| Total liabilities | 6,421 | 5,381 |
| Stockholders' equity | 3,245 | 3,393 |
| Total liabilities and equity | 11,215 | 10,218 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/27/25 | 13,184 | 653 | 398 | 3.0 | 3.27 | – | 712 | 139 | 573 | 11,215 | 6,421 | 3,107 | 3,245 | 12.3 | 0.96 |
| 12/28/24 | 12,673 | 621 | 390 | 3.1 | 3.05 | – | 848 | 148 | 700 | 10,218 | 5,381 | 2,536 | 3,393 | 11.5 | 0.75 |
| 12/30/23 | 12,339 | 615 | 416 | 3.4 | 3.16 | – | 500 | 147 | 353 | 10,573 | 5,420 | 2,351 | 3,655 | 11.4 | 0.64 |
| 12/31/22 | 12,647 | 747 | 538 | 4.3 | 3.91 | – | 602 | 96 | 506 | 8,607 | 3,936 | 1,149 | 3,446 | 15.6 | 0.33 |
| 12/25/21 | 12,401 | 852 | 631 | 5.1 | 4.45 | – | 710 | 79 | 631 | 8,481 | 3,805 | 873 | 3,425 | 18.4 | 0.25 |
| 12/26/20 | 10,119 | 535 | 404 | 4.0 | 2.82 | – | 599 | 49 | 550 | 7,773 | 3,460 | 699 | 3,348 | 12.1 | 0.21 |
| 12/28/19 | 9,986 | 718 | 695 | 7.0 | 4.65 | – | 654 | 76 | 578 | 7,151 | 3,234 | 757 | 2,998 | 23.2 | 0.25 |
| 12/29/18 | 13,202 | 601 | 536 | 4.1 | 3.49 | – | 685 | 71 | 613 | 8,501 | 4,647 | 1,964 | 2,961 | 18.1 | 0.66 |
| 12/30/17 | 12,462 | 670 | 406 | 3.3 | 2.57 | – | 546 | 62 | 483 | 7,864 | 4,207 | 924 | 2,811 | 14.5 | 0.33 |
| 12/31/16 | 11,572 | 772 | 507 | 4.4 | 3.10 | – | 643 | 70 | 572 | 6,812 | 3,352 | 781 | 2,793 | 18.1 | 0.28 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
HENRY SCHEIN INC
CIK 1000228 · EIN 11-3136595
PRINCIPAL OFFICE:
135 Duryea Rd, Melville, NY 11747
Tel.: 6318435500
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
5047 · Wholesale-Medical, Dental & Hospital Equipment & Supplies
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/27/25, filed 24 February 2026
FORMER NAMES:
SCHEIN HENRY INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/24/26) · 10-K FY2024 (filed 2/25/25) · 10-K FY2023 (filed 2/28/24) · 10-K FY2022 (filed 2/21/23) · 10-K FY2021 (filed 2/15/22) · 10-K FY2020 (filed 2/17/21) · 10-K FY2019 (filed 2/20/20) · 10-K FY2018 (filed 2/20/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.